Project information
Personalised Cardio–Renal–Metabolic Therapeutic Strategies in Alström Syndrome Through Multi-Omics Stratification and Advanced Human Disease Models
- Project Identification
- EPPERMED2026-086
- Project Period
- 1/2027 - 12/2029
- Investor / Pogramme / Project type
-
Ministry of Health of the CR
- Programme NW (2024 - 2030)
- Subprogram 3 - European Partnerships
- MU Faculty or unit
- Faculty of Medicine
Alström syndrome is a rare inherited disease that affects several organs at the same time, particularly the heart, metabolism and kidneys. People with Alström syndrome can develop heart disease, diabetes and kidney failure at a young age, but the severity and speed of disease progression vary greatly from one patient to another. This variability makes it difficult to predict outcomes and to choose the most effective treatment for each individual. The aim of this project is to develop personalised treatment strategies for people with Alström syndrome by better understanding the biological differences between patients. We will analyse a wide range of biological data from patients, including genetic information, blood markers and metabolic profiles, together with clinical data such as heart imaging, kidney function and treatment history. This integrated approach will allow us to identify molecular “signatures” that can predict disease progression, treatment response and possible side effects.